National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 249 cases where Vaccine is HPV or HPV2 or HPV4 and Symptom is Mental disability or Mental disorder or Mental disorder due to a general medical condition or Mental impairment or Mental retardation or Mental retardation severity unspecified or Mental status changes

Case Details

This is page 2 out of 25

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next


VAERS ID: 318052 (history)  
Form: Version 1.0  
Age: 21.0  
Sex: Female  
Location: Ohio  
Vaccinated:2007-08-24
Onset:2007-09-01
   Days after vaccination:8
Submitted: 2008-07-01
   Days after onset:304
Entered: 2008-07-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0930U / 2 LA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Abasia, Asthenia, Blood test, Chromosomal analysis, Computerised tomogram, Disability, Dizziness, Eating disorder, Electroencephalogram, Electromyogram, Facial palsy, Gastrointestinal disorder, Gene mutation identification test, Hair metal test, Headache, Local swelling, Loss of control of legs, Lumbar puncture, Mental disorder, Nausea, Nervous system disorder, Neuropathy peripheral, Pain, Pain of skin, Paraesthesia, Photophobia, Pupillary disorder, Skin burning sensation, Swelling face, Syncope, Urine analysis
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Angioedema (narrow), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious meningitis (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Glaucoma (broad), Cardiomyopathy (broad), Corneal disorders (broad), Retinal disorders (broad), Hearing impairment (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations: None~ ()~~0.00~Patient
Other Medications: Topomax 50 mg 1 per day
Current Illness: None
Preexisting Conditions: Fibromyalgia, chemical sensitivity, migraines. PMH: fibromyalgia, migraines, asthma, hernia surgery, abd surg.
Allergies:
Diagnostic Lab Data: MRI, CTscan, LP, Multiple Blood tests, Sed rate checked multiple times, DNA tests, Urine analysis, EEG, EMG. Hair analysis. Labs and Diagnostics: CXR WNL. Lumbar MRI Unremarkable. Cervical MRI Unremarkable. Thoracis MRI Unremarkable. Brain MRI reported as WNL.CBC WNL. UA WNL. Sed rate 36 and 47. CRP 2.0. Chem unremarklable. IGA,G, and M all WNL. MPA Serum Lambda high at 687. CSF reportedly WNL, CSF protein 31.
CDC Split Type:

Write-up: Aug.24, second Gardasil injection received. Sept.3, pressure in jaw and head began, followed by weakness, severe pain and loss of use of legs; nausea, dizziness, fainting, swelling and drooping of face and neck. Oct.2007, lost ability to walk, burning prickles in scalp, hands, legs. Seen by several specialists including hospital neurological teams- no diagnosis given. Seen by multiple specilists Jan. 2008 - June 2008. Unable to eat solid foods, placed on liquid diet. Finally diagnosed by D.O. as having an adverse reaction to Gardasil. Special diet and pain medication given which seem to be helping in small degrees. We were told it would be a long time recovering. 2nd report 320256. 07/23/2008 MR received for DOS 10/19-24/2007 which include 2 Rheumatology consults, neuro consult, psych consult and inpt admission. Pt presented for Rheum eval 10/19/07 with c/o 6 week hx of pain and sensitivity in her face, jaw neck and thoracic region (burning & tingling) and progressive weakness in her limbs. Unable to walk without assistance. Pt reports dizziness, vertigo, syncope and photosensitivity. Sleep is disturbed. Several falls. Has sweats. Presents in sunglasses for photophobia and in a w/c. This followed a viral and /or sinus infection 6 weeks prior. PE (+) for anceiform rash on the back, scalp, face, jaw, and neck tenderness, DTRs 1+ arms, unobtainable in legs, decreased strength in arms and legs, unable to walk. Concern for neurological illness resulted in emergent admission to hospital for further eval. DOS 10/19-24/2007 with DX: weakness. other dx: fibromyalgia, migraines, asthma and chronic pain syndrome. Neuro consult as above but able to elicit patellar reflexes. Psych eval to r/o conversion d/o. Requested further eval. 2nd Rheum consult for increased sed rate. Additional sx of touch sensitivity and lower extremity numbness. Impression: Elevated Sed rate. Myalgia and myositis NOS, Headache, Difficulty in walking. Pt had some nausea and vomiting while admitted. Treated for pain and pt was ambulating on her own by d/c. No final dx made. D/C to f/u at home. 4/6/09 Received call from pt''s current MD. Has not been able to fully evaluate pt as pt has been unable to travel. Unable to confirm GBS dx. Current dx is conversion d/o./pc 1/25/2010 Follow up: She is considered disabled due to the GARDASIL vaccine. SHe has perpherial neuropathy in both legs (from the knees down) she has nervous systmen pain; brain fog; eye sensitivity/abnormal pupuilary responsive and dilations; GI tract disorders.


VAERS ID: 325604 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Missouri  
Vaccinated:2008-06-18
Onset:2008-09-01
   Days after vaccination:75
Submitted: 2008-09-19
   Days after onset:18
Entered: 2008-09-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0928U / 1 LA / IM

Administered by: Private       Purchased by: Public
Symptoms: Electromyogram normal, Gait disturbance, Lipids normal, Lumbar puncture normal, Mental disorder, Muscular weakness, Nuclear magnetic resonance imaging normal
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Dementia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 9 days
   Extended hospital stay? No
Previous Vaccinations: ~HPV (Gardasil)~UN~0.00~Sibling
Other Medications: None at time of vaccination
Current Illness: None
Preexisting Conditions: None PMH: GERD, scoliosis, asthma, learning disability, sensorineural hearing loss, hearing aids, allergy: toradol (itchy rash). Birth twin, sibling expired. Frequent bronchitis & pneumonia but no hospital admissions until 8/08. Parents smoke, 4 kittens in home & several outside dogs, ovarian cyst, fx right ankle x 2 yr ago.
Allergies:
Diagnostic Lab Data: MRI, EMG, LP-normal, working with psychiatry 9/5 labs: WBC 21.0(H), 9/6 labs: potassium 3.2(L), calcium 8.2(L), total protein 5.4(L), ALT 68(H), x-ray of spine WNL. 9/12 LABS: MRI, LP, EMG/NCS. AST/ALT 103/185(H). CK 40(L). ESR 10. CSF: WBC 1, RBC 63, glucose 60, protein 38. CSF & urine c/s neg. ALT 98(H), stool c/s neg. 9/21/08 LABS: ALT 79(H), alk phos 56 (L), CT of head WNL.
CDC Split Type:

Write-up: Muscle weakness, trouble walking, psychiatric changes - starting early September. 9/30/08 Reviewed hospital medical records of 9/21-9/22/08. FINAL DX: facial palsy, weakness, slurred speech Records reveal patient had asthma exacerbation requiring intubation & ICU stay shortly s/p HPV injection. While in ICU began having thigh & back pain & weakness which progressed over 3 wks until unable to walk. Developed slurred speech, HA & tongue deviation. Had been seen in other hospitals & w/u WNL. 10/21/08 Reviewed hospital records of 9/12-9/17/2008, ER records of 9/5-6/08. FINAL DX: no d/c summary available Records reveal patient experienced asthma exacerbation & hospitalized 8/08 in PICU. Developed leg pain, toes pointing in w/walking, tingling in toes, numbness in forearms that resolved. Seen by PCP & labs revealed elevated LFTs. Leg pain progressed & had difficulty walking, HA, back pain. Seen in ER 9/6/08. admitted 9/9/08 for evaluation of possible GBS. CSF & EMG were WNL & developed n/v s/p spinal tap. Had missed several weeks of school. Neuro eval WNL. 10/7/08 Reviewed hospital medical records of 9/9-9/12/2008. FINAL DX: LE pain & weakness; elevated liver enzymes Records reveal patient experienced pain in back & extremities, ataxia, swelling of feet/ankles, numbness/tingling left arm, unable to walk, drug induced HA & skin rash(tegretol). Neuro consult done. Transferred per parental request. 1/27/2010 Was seen by several neurologist-multiple test done and no abnormalities found to explain her symptoms. More than on newurologist suggested her symptoms were related to a "conversion reaction" and suggested psychiatry evaluation.


VAERS ID: 330413 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2008-01-14
Onset:2008-01-22
   Days after vaccination:8
Submitted: 2008-10-28
   Days after onset:279
Entered: 2008-10-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 3 LL / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Autoimmune disorder, Body temperature increased, Dizziness, Electroencephalogram abnormal, Fear, Hallucination, visual, Injection site pain, Mental disorder, Nuclear magnetic resonance imaging normal, Presyncope
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Psychosis and psychotic disorders (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Adderall XR 10mg
Current Illness: None
Preexisting Conditions: ADD- short term memory & comprehension problems
Allergies:
Diagnostic Lab Data: 5/7/2008 EEG -(Showed spikes) 5/9/2008 MRI - ok After being off Seroquel for 1 month 7/9/2008 EEG - (no spikes) 7/23/2008 MRI - ok
CDC Split Type:

Write-up: Patient had her HPV shot on 1/14/08 at 3pm. Patient had started back on Adderall 10mg in January after taking a 6 month break. She got very light headed 1 hour after her shot and almost fell in the bathroom at home. A couple of days later, she had a temp of 104 degrees for 2 day. Tylenol was given every 4 hours with no real aid in dropping the fever. The 2nd night of the high temp, she had a vision of a boy standing by her bed in the middle of the night. The boy was not real. The temp broke that night. In March, patient saw the vision of the boy by her bed in the middle of the night again. This continued to happen on an inconsistant bases, but by April she was seeing different visions of people during the day and night all of the time. She saw pediatrician on April 15, 2008. She was told to stopped taking the Adderall. Patient was set up with an appointment with psychiatry on April 23. Patient began Seroquel for her visions and numerous psychiatry appointments. After trying different doses, she continued on 1/2 pill per day until the end of May 2008. The visions went away after the second day of Seroquel. Patient also has a major fear of having any thing injected into her or taken out of her (example, immunizations and blood draws). She said the HPV shot hurt and you could feel the medicine go into your body. She had sessions to desensitize her to have a blood draw done. The blood draw did show that her Auto-immune numbers were at 40. We have not followed up on this yet.


VAERS ID: 331142 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2008-07-01
Onset:2008-10-01
   Days after vaccination:92
Submitted: 2008-11-03
   Days after onset:33
Entered: 2008-11-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0070X / 1 RA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Arthralgia, DNA antibody positive, Encephalitis, Mental status changes, Systemic lupus erythematosus
SMQs:, Systemic lupus erythematosus (narrow), Dementia (broad), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: OCPs
Current Illness: none
Preexisting Conditions: none 11/14/08-records received-PMH: recent diagnosis of lupus last week on prednisone.
Allergies:
Diagnostic Lab Data: 11/14/08-records received-ANA positive. CT sinusitis. MRI consistent with lupus cerebritis. Echocardiogram normal. WBC 22.4, absolute neutrophil count increased 18.82, ESR increased 87, CSF glucose low 59, oligo bands albumin , serum 3330 low. Phospholipid IgM antibodies positive 48.6, angio normal carotid arteries. MRI brain multiple nonspecific punctate foci of T2 prolongation are seen in bifrontal deep white matter, compatible with gliosis possibly 12/1/08-records received-EEG normal.
CDC Split Type:

Write-up: Patient developed arthralgias, change in mental status. Diagnosed with Systemic Lupus Erythematous on 10/23, based on +ANA and +dsDNA. Admitted to Hospital for changes in mental status, thought to be from lupus cerebritis. records received 11/14/08-presented to ED 10/28/08-C/O short term retrograde amnesia. Intermittent blurry vision. C/O joint pain, headaches nausea for 4 weeks. Left hand weakness. One and half months prior C/O pain in hands and feet, isolated papules. Difficulty sleeping. 12/1/08-DC summary received for DOS 10/28-11/6/08-DX:Lupus cerebritis. Change in mental status.


VAERS ID: 339414 (history)  
Form: Version 1.0  
Age: 21.0  
Sex: Female  
Location: Unknown  
Vaccinated:2007-08-13
Onset:2007-12-01
   Days after vaccination:110
Submitted: 2009-02-10
   Days after onset:437
Entered: 2009-02-11
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0928U / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Affective disorder, Blood aluminium, Mental disorder
SMQs:, Dementia (broad), Psychosis and psychotic disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: LOESTRIN 24 FE
Current Illness: Allergic reaction to antibiotics; sulfonamide allergy
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Serum Al
CDC Split Type: WAES0902USA01069

Write-up: Information has been received from a nurse practitioner concerning a 22 year old female patient with no pertinent medical history and allergic reaction to AUGMENTIN, CECLOR, and sulfonamide allergy who on 13-AUG-2007 was vaccinated with the first dose of GARDASIL (Lot # 658554/0928U) intramuscularly. On 29-FEB-2008 the patient received the second dose of GARDASIL (Lot # 660557/0072X). Concomitant therapy included LOESTRIN 24. It was reported that in December 2007 the patient developed mental illness which consisted of mood disorder after receiving GARDASIL. It was reported that the patient had not yet received the third dose. A serum level test for aluminum was performed (result not provided). It was reported that the patient had been hospitalized due to the disorder, but the reporter did not know the duration of the hospitalization. Additional information has been requested.


VAERS ID: 339457 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2007-03-28
Onset:2007-05-02
   Days after vaccination:35
Submitted: 2009-02-11
   Days after onset:651
Entered: 2009-02-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0244U / 1 LA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Acute disseminated encephalomyelitis, Dizziness, Fatigue, Headache, Hypersomnia, Mental disorder, Nuclear magnetic resonance imaging brain abnormal, Visual impairment
SMQs:, Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Glaucoma (broad), Optic nerve disorders (broad), Demyelination (narrow), Lens disorders (broad), Retinal disorders (broad), Depression (excl suicide and self injury) (broad), Vestibular disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Adjustment reaction with depressed mood 2/24/09-records received-PMH: Chronic tension headaches, neck and shoulder tension. Headaches for many years but now worse. Double vision. Stated always had tracking issues with reading. Strep throat 5/7/07.Allergy to penicillin.
Allergies:
Diagnostic Lab Data: MRI of brain consistent with A.D.E.M. 4/24/09-records received-MRI abnormal signal in brainstem without regional mass effect. Compatible with demyelinating disease. T2 signal abnormality. MRI showed ADEM. Follow-up MRI yesterday showed improvement.
CDC Split Type:

Write-up: Developed symptoms of severe headache, fatigue, dizziness, abnormal vision and excessive sleeping on about 5/2/2007, 5 weeks after receiving HPV #1 and about 1 week after diagnosis of acute Group A strep throat on 4/26/2007. She continued to have prolonged symptoms and MRI of brain was performed on 5/23/07 and was consistent with Acute disseminating encephalomyelitis. She was hospitalized for several days and treated with IV steroids and bed rest. She had a prolonged convalescence but for the most part all symptoms had completely resolved by August 2007 except for continued headaches for which she takes amytriptline rather regularly. She continues to have psychologic issues, but these pre-dated HPV vaccine and I do not think they are the result of HPV. She sees a psychologist regularly. She has not received any further HPV due to concern about possible connection with her A.D.E.M. 2/24/09-records received for DOS 5/30-6/2/07-DC DX:post lumbar puncture headache. Acute disseminated encephalomyelitis (ADEM). One month prior received treatment for infectious cerebellitis and a diagnosis of ADEM 2-3 weeks prior to admission. Prior to lumbar puncture C/O confusion and disorientation. Presented with vomiting and headache. Lower back pain. Blood patch performed. Eye consult 5/23/07-C/O sudden onset horizontal diplopia, dizziness and movement of the environment. 3/23/09-additional information recieved-presented on 5/30/07- with C/O headaches after lumbar puncture. 2-3 weeks ago developed diplopia and a gait imbalance,


VAERS ID: 340614 (history)  
Form: Version 1.0  
Age: 12.0  
Sex: Female  
Location: Illinois  
Vaccinated:2007-10-01
Onset:2007-10-01
   Days after vaccination:0
Submitted: 2009-02-13
   Days after onset:501
Entered: 2009-02-18
   Days after submission:5
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1446U / 3 UN / IM

Administered by: Private       Purchased by: Other
Symptoms: Abdominal distension, Acute hepatic failure, Alanine aminotransferase normal, Alopecia, Amenorrhoea, Arthralgia, Aspartate aminotransferase normal, Autoimmune hepatitis, Blood albumin decreased, Blood alkaline phosphatase increased, Blood bilirubin increased, Blood chloride normal, Blood creatinine decreased, Blood glucose decreased, Blood potassium normal, Blood sodium normal, Blood urea increased, Dialysis, Encephalopathy, Endotracheal intubation, Extubation, Haematocrit decreased, Haemoglobin decreased, Jaundice, Leukocytosis, Liver function test abnormal, Liver transplant, Mean cell volume normal, Mental impairment, Oedema peripheral, Platelet count normal, Protein total decreased, Pyrexia, Red blood cell count decreased, Red cell distribution width increased, Renal failure acute, Respiratory failure, Skin discolouration, Skin papilloma, Tachycardia, Weight increased, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Cardiac failure (broad), Liver related investigations, signs and symptoms (narrow), Cholestasis and jaundice of hepatic origin (narrow), Hepatitis, non-infectious (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Anaphylactic reaction (broad), Acute pancreatitis (narrow), Angioedema (broad), Haematopoietic erythropenia (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dementia (broad), Acute central respiratory depression (narrow), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Fertility disorders (broad), Hypotonic-hyporesponsive episode (broad), Chronic kidney disease (narrow), Hypersensitivity (broad), Arthritis (broad), Tumour lysis syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Hypoglycaemia (narrow), Dehydration (broad), Hypokalaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 90 days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: WBC count, 04/22/09, 12.89; red blood cell count, 04/22/09, 3.15; hemoglobin, 04/22/09, 9.2; hematocrit, 04/22/09, 27.5; mean corpuscular volume, 04/22/09, 87.3; RDW, 04/22/09, 17.1; platelet count, 04/22/09, 338; serum sodium, 04/22/09, 142; serum potassium, 04/22/09, 4.4; serum chloride, 04/22/09, 109; serum alanine, 04/22/09, 30; serum blood urea, 04/22/09, 50; serum creatinine, 04/22/09, 2.9; serum glucose, 04/22/09, 100; total serum bilirubin, 04/22/09, 2.4; serum albumin, 04/22/09, 2.4; total serum protein, 04/22/09, 4.3; serum aspartate, 04/22/09, 19; serum alkaline, 04/22/09, 164
CDC Split Type: WAES0901USA01986

Write-up: Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had an increase in weight gain and hair loss since she started the GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009: the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenorrheic for almost one year. It was reported that the patient was no taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility problems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. Additional information has been requested. This is in follow-up to report (s) previous submitted on 1/11/2009, 8/7/2009. Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had increase in weight gain and hair loss since she started GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009, the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenhorrheic for almost, one year. It was reported that the patient was not taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility prolems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL, intramuscularly. Follow up information has been received from a physician and a doctor of pharmacy via medical records, concerning a 14 year old female black patient with no known illness at time of vaccination, no known pre-existing allergies and unremarkable past medical history. The doctor of pharmacy reported that after the first injectiona wart occurred on the patient''s scalp and she became amenorrhaic and lost her hair. After the second and third injection she has skin discoloration, swellling of legs and stomach and weight gain. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL intramuscularly. In February 2009, the patient presented to her primary care physician with lower extremity adema and was found to have elevated liver function test. The physician reported that the patient was ultimately diagnosed with Autoimmune hepatitis and was compliant with outpatient treatment. The patient came to the emergency department (inj on 13-MAR-2009 with complaints of joint pain and jaundice, and was admitted to the pediatric intensive care unit for decompensationdue to liver disease. The patient''s liver function rapidly deteriorated, as well as her mental status, and she required intubation as well as dialysis for acute drenal failure. She was placed on the liver transplant on 26-MAR-2009. She was able to be extubated on post operative day#1. Postoperatively she was still required dialysis for approximately 3 weeks ntil she began to make urine. Her last dialysis was on 11-APR-2009, after this her creatinine began to decline. Her LFTs also improved to normalised. She had occasional fevers and leukocytosis for which no source of infectionwas found via cultures or imaging, including computer axial tomography scan. Her white blood cell count eventually began to decline. The patient was deemed stable for discharge home on 22-APR-2009. The patient''s labs on discharge were as follows: White blood cell count: 52.89; red blood cell count, 3.15; blood hemoglobin, 9.2; whole blood hematocrit, 27.9, mean corpuscular volume, 97.3, red cell distribution width test, 17.1; blood platelet count, 398, serum sodium test, 142; serum potassium test, 4.4; serum chloride test, 109; total serum carbon dioxide test, 22; serum blood urea nitrogen test, 59; serum creatinine test, 2.9; serum glucose test, 100; serum alkaline phosphatase test, 164; serum albumin test, 2.6; total serum protein test, 6.3; serum aspartate aminotransferase test, 1%; serum alanine aminotransferase test, 10; total serum billirubin, 2.4. The patient''s final diagnoses were fulminant liver, autoimmune hepatitis, status post liver transplant, acute renal failure (resolved), respiratory failure (noted 25-MAR-2009; resolved 11-APR-2009). Activehospital problems included tachycardia and artharlgia. Resolved hospital problems include encephalopathy (noted 20-MAR-2009). The patient requires hospitalization for 90 plus days. The physician reported that patient''s discharged procedure orders were physicial and occupational therapy with bilateral full weight bearing (weight bearing as tolerated). The discharge medications include: PROTONIX 40mg tablet, PO daily; PROGRAF, 5 mg PO. capuls, two times daily; PROGRAF, 1 mg PO capsule, 4 Capaules two times daily, IMODIUM, 2 mg PO capsule, two times daily as needed for diarrhea/loose stools, kopran, 4 MG po tablet, every 6 hours as needed for nausea, NEUROTIN, 300 mg, PO, capsule tow times daily, CELLCEPT, 250 mg PO capsule, 2 capsules 12 hours, MYCOSTATIN, 100,000 unit/mL PO oral suspension, BACTRIM DS, 260-500 mg PO tablet, every Monday, Wednesday, and Friday morning, DELTASONE, 5 mg PO tablet, 2 tablets every morning. The physician recommended to stop taking ACTIGALL, 100 mg, PO capsule, ALDACTONE, 100 mg PO tablet, multivitamin PO, PURINETHOL, 50 mg PO tablet. Autoimmune hepatitis, hepatic failure, hair loss, skin discoloration, ward occurred on the scalp, respiratory failure, renal failure, weight increased, encephalopathy and amenorrhoea were considered to be other important medical events. Autoimmune hepatitis, hepatic failure, encephalopathy. Acute renal failure and respiratory failure were considered to be disabling and life threatening. Follow up information was received from a registered nurse who reported that on 11-AUG-2007 the patient was vaccinated with the first dose of GARDASIL (Lot No. 658282/0929U). On 13-OCT-2007 (also reported as 290OCT-2007) the patient was vaccinated wish the second dose of GARDASIL. Subsequently, on 26-FEB-2009 the patient was vaccinated with the third dose of GARDASIL (Lot No. 659441/1446U). The nurse was unable to provide the patient''s current status. A lot check has been initiated. No further information is available. All available medical records will be provided upon request.


VAERS ID: 342787 (history)  
Form: Version 1.0  
Age: 22.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2008-09-02
Onset:2008-09-02
   Days after vaccination:0
Submitted: 2009-03-26
   Days after onset:205
Entered: 2009-03-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0573X / 2 LA / UN

Administered by: Private       Purchased by: Private
Symptoms: Abdominal pain upper, Asthenia, Blood heavy metal increased, Diarrhoea, Dizziness, Eating disorder, Epstein-Barr virus antibody positive, Headache, Hypoaesthesia, Immediate post-injection reaction, Lethargy, Mental impairment, Myalgia, Pain in jaw, Temporomandibular joint syndrome, Weight decreased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Anticholinergic syndrome (broad), Dementia (broad), Pseudomembranous colitis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Vestibular disorders (broad), Osteonecrosis (broad), Hypersensitivity (narrow), Arthritis (narrow), Noninfectious diarrhoea (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Diagnosed with TMJ. Full blood work-up shows signs of Epstein Barre
CDC Split Type:

Write-up: Immediate weakness, lethargic, muscule pain in all extremities. Continued to remain ill for months with dizziness, stomach pains, diahrea, numbness in arms, hands and fingers, jaw pain, unable to eat for prolonged periods (going from 103 lbs to 89 lbs) Experienced mental fuzziness and continues to feel numb on left side of body. Bad headaches. Is still being treated by Kinesiologist for high levels of metal in body. Had full blood work-up on 3/21/09. Continues to experience illness due to vaccine. Was perfectly healthy prior to second vaccine .


VAERS ID: 346337 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Virginia  
Vaccinated:2006-12-15
Onset:2006-12-21
   Days after vaccination:6
Submitted: 2009-05-14
   Days after onset:874
Entered: 2009-05-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0637F / 1 UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Arthralgia, Blood cortisol increased, Blood fibrinogen decreased, Blood immunoglobulin G increased, Blood immunoglobulin M increased, Borrelia burgdorferi serology, Cardiac monitoring, Cellulitis, Computerised tomogram abnormal, Culture stool positive, Echocardiogram normal, Electrocardiogram normal, Epstein-Barr virus antibody positive, Gastrointestinal disorder, Herpes simplex serology, Hypoaesthesia, Insomnia, Intervertebral disc degeneration, Intervertebral disc disorder, Lipoprotein (a) increased, Lyme disease, Mental status changes, Muscular weakness, Nuclear magnetic resonance imaging normal, Parasite blood test, Parvovirus B19 serology, Pharyngitis streptococcal, Postural orthostatic tachycardia syndrome, Rheumatoid arthritis, Streptococcus identification test, Streptococcus identification test positive, Upper respiratory tract infection, Urinary tract infection, Urine analysis abnormal, Vitamin D decreased
SMQs:, Rhabdomyolysis/myopathy (broad), Liver-related coagulation and bleeding disturbances (narrow), Agranulocytosis (broad), Dyslipidaemia (narrow), Peripheral neuropathy (broad), Haemorrhage laboratory terms (broad), Dementia (broad), Oropharyngeal infections (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypersensitivity (broad), Arthritis (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: Mono diagnosed 5/2006 - shot given 12/2006 at pediatrician''s urging
Preexisting Conditions: None. 7/21/09 Medical records received DOS 1/24/08 to 4/9/09. Tonsillectomy. Infectious mononucleosis, chronic fatigue syndrome. Spinal tap headaches, Strep throat, ADD, ruptured ovarian cyst. Rheumatoid arthritis. Has abused alcohol and used drugs. 7/27/09 Hospital records received DOS 5/9/09 to 5/11/09. Allergies to hydrocodone and provigil. Babesiosis.
Allergies:
Diagnostic Lab Data: Head MRI-normal, Cat scan body-normal except for mild degenerative disc disease of the thoracolumbar junction, Lyme IgE nex 41k 58k IgG positive-IgM 30+, 31-ind, 39-ind, 41-ind, babesia 1:20 igm titer, CD57-low, EBV IgG high, parvo-IgG high, crystal mucus threads in urine, vit D low, succinic acid high, in stool - moderate candida albicans, moderate staph, abundant gamma hemolytic streptococcus, abundant yeast, ASO titers high 11/2 years (over 1000), normal echo and EKG, high morning cortisol, m. pneumonie ab IgG high, herpes 6 IgG high, fibrogen low, abnormally low chymotyrpsin in stool, bilateral disc osteophyte complex mildly narrowing neural foramen C4-5 C5-6, osseous structures demonstrate endplate discogenic changes at several lower thoracic levels, high lipoprotein, dhea sulphare high, heart monitor for POTS. 7/21/09 Medical records received DOS 1/24/08 to 4/9/09. LABS and DIAGNOSTICS: X-ray Spine - Slight degenerative change at C5/C6. FDA Unapproved Lyme disease test positive. EBV IgG and EBV nuclear antigen titers elevated. Parvo IgG Elevated. 7/24/09 Cardial consultant records received DOS 4/22/09. LABS and DIAGNOSTICS: EKG - WNL. Echocardiogram - WNL. 7/27/09 Hospital records received DOS 5/9/09 to 5/11/09. LABS and DIAGNOSTICS: MRI Brain - Soft tissue swelling cheek, left medial canthus, left inferior preseptal tissues. CBC - RBC 3.61 /CMM (L) HGB 11.1 g/dl (L) RDW 15.2% (H) Lymph 16.8% (H) Eos 7.7% (H). CHEM - Glucose 48 mg/dL. TSH 3rd Gen 0.326 mlU/L (L) Free Thyroxine 0.71 ng/cL (L). ASO Titer (+). CRP (-). Blood Culture - no growth. Parvovirus B19 Antibody IgG 5.38 IV. Parvovirus B19 Antibody IgM 0.21 IV. Rheumatoid Factor (-). 11/6 & 11/9/09:Medical records and labs and diagnostics received from dates of service 5/12/06 to 3/19/09: Labs and diagnostics:Cortisol 24.7 (H), LH <0.2 (L), FSH <0.7 (L), Magnesium 3.9 (L), EBV AG $g 5.00 (H), ASO AB 1049 (H), Fibrinogen 152 (L), EBV Ab IGG 1535 (H), EBV Nuclear Antigen 1183 (H), Mono Screen +, Atypical lymphocytes 19 (H), Segmented neutrophils 21 (L), WBC 3.6 (L), P 41 AB Present, P 58 AB Present, Lymphs. 57 (H), BUN 5.7 (L), Glucose 119 (H), ALT 145 (H), AST 87 (L). CSF RBC''s 1036 (H).
CDC Split Type:

Write-up: During the series of 3 injections and after the patient developed utis, uris, strep throat 3 times, joint pains, muscle weakness, numbness, insomnia, mental status changes, POTS, clinical Lyme disease, rheumatoid arthritis, gastrointestinal disturbances following vaccination of Gardasil. Two years later still has not recovered. Recently developed presepal cellulitis and was hospitalized. 7/21/09 Medical records received DOS 1/24/08 to 4/9/09. Assessment: Chronic pain in neck, back, and mid spine region. Patient presents with missing school, severe joint pain neck and back - hurt all the time. Reports eyes dilated. Constantly tired. Pain also shoulders, wrists, hands, ankles, feet. Difficulty walking. Hypersensitive. emotional. Acute tracheitis, sore throat. Myalgias, myositis. Fibromyalgia. Feels sad. Depression, difficulty sleeping. Parent says patient "talking crazy things" and wanted to kill herself. Crying hysterically. Therapeutic abortion. Cafe-au-lait spots noted. Limitation of cervical range of motion. 7/24/09 Cardial consultant records received DOS 4/22/09. Assessment: Chronic fatigue, chronic Lyme disease, autonomic disfunction, postural orthostatic tachycardia syndrome. Patient presents with dizziness, ''declining cognitive'' and poor memory. Frequent headaches and insomnia. Generalized body aches. Nausea. Hand and feet are cold. Head felt foggy, lightheaded. ''Marijuana intake'' 7/27/09 Hospital records received DOS 5/9/09 to 5/11/09. Discharge Diagnosis: Severe Periorbital Cellulitis, Chronic Lyme Disease, Seronegative Rheumatoid Arthritis, Post reactive Streptococcal Arthritis, and POTS, Chronic pain/chronic opiates, Polyarthralgia, Euthyroid Sick Syndrome. Patient was extracting blackheads and plucking ingrown eyebrow hairs, presents with red swollen right eyelid and face with prurulent areas, tenderness, scaling. Marked facial erythema and edema on the right, left side much less red and swollen. Honey-crusted papules. Difficulty opening right eye. Poor eye contact, flat affect. Drowsy. Follow-up: Pt has whole body joint and muscle pain, nausea -$g now diagnosed as gastroparesis, POTS, fatigue, brain fog, menstrual irregularity (no period since 9/09), heartburn, heart palpitation), chills, sweats, difficulty concentrating, anxiety, light and sound sensitivity. This vaccine has completely destroyed my child''s health. Previously Pt was a year round athlete; now she can not walk up stairs without difficulty. This vaccine needs to be taken off the market immediately before more girls are maimed and their health destroyed. She has seen over 20 or 30 specialists, tried many prescription drugs for her symptoms and still has not recovered. I am furious that the government has allowed her to be a guinea pig for pig pharma. Why has no action been taken? Why has a placebo that is a carrier solution of neurotoxic aluminum, rat poison sodium borate, and mice infertility poly sorbate 80 allowed instead of sarcine. No wonder Merck''s studies of placebo and vaccine has similar adverse events -$g both have the same poison. Look at Mercks 400+ page study submitted to the FDA/CDC. Adverse events and new medical conditions run from 50 to 75% for both groups! Open your eyes. Girls are becoming disabled and dying!


VAERS ID: 352326 (history)  
Form: Version 1.0  
Age: 26.0  
Sex: Female  
Location: Unknown  
Vaccinated:2009-06-25
Onset:2009-06-25
   Days after vaccination:0
Submitted: 2009-07-15
   Days after onset:20
Entered: 2009-07-17
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0087Y / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Asthenia, Fatigue, Mental impairment
SMQs:, Dementia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX; ADDERALL TABLETS; CLEOCIN; NUVARING; ZOLOFT;AMBIEN
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0906USA05359

Write-up: Information has been received from a registered nurse concerning a 26 year old female who on 25-JUN-2009 was vaccinated with the first dose of GARDASIL (lot# 662518/0087Y, 0.5ml, route and site of administration not reported). Concomitant therapy included (ZOLOFT), amphetamine (ADDERALL TABLETS), (XANAX), (AMBIEN), (CLEOCIN) and (NUVARING). The patient''s relevant medical history and past drug history were unknown. On 25-JUN-2009 the patient reported feeling weak, tired and mentally slow. As of 25-JUN-2009 the patient was still feeling weak, tired and mentally slow. It was unknown if the patient would continue to take the GARDASIL vaccine. Additional information has been requested.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=2&SYMPTOMS[]=Mental_disability_%2810027353%29&SYMPTOMS[]=Mental_disorder_%2810061284%29&SYMPTOMS[]=Mental_disorder_due_to_a_general_medical_condition_%2810061285%29&SYMPTOMS[]=Mental_impairment_%2810027374%29&SYMPTOMS[]=Mental_retardation_%2810027378%29&SYMPTOMS[]=Mental_retardation_severity_unspecified_%2810027380%29&SYMPTOMS[]=Mental_status_changes_%2810048294%29&VAX[]=HPV&VAX[]=HPV2&VAX[]=HPV4


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166